Aidite Secures Hundreds of Millions in New Funding to Advance Dental Materials R&D and Build a Digital Oral Healthcare Ecosystem

VCBeat (WeChat: vcbeat) has learned that Aidite (Qinhuangdao) Technology Co., Ltd. (“Aidite”) has just announced the completion of a new round of financing, with the transaction amount reaching hundreds of millions of yuan.

This round of financing was led byChende Capital, which focuses on the life sciences and medical technology sectors, andZhongjin QichenLead investor; Xiamen C&D Venture Capital co-invested, previously, Aidite had received investment from Legend Capital, globally renowned asset management companies Schroders Adveq and Adam Street Partners (ASP)Investment of hundreds of millions of yuan. It is reported that this round of financing will be mainly used for the construction of the company's digital oral care system.

Aidite is a global, high-tech group enterprise focused on the research and development of dental materials, integrating the upstream and downstream segments of the dental industry chain. Since its inception, Aidite has remained dedicated to novel dental materials, developing related consumables, intelligent equipment, and new technologies, while enriching its services and training programs. The company is committed to transforming traditional dentistry and truly realizing the digitalization and intelligent development of the international dental industry.

Currently,Aidite is a global leader in the research and development of zirconia and glass-ceramic materials.The Company has established offices in five cities: Beijing, Shanghai, Xi’an, Chengdu, and Shenzhen. It has set up overseas subsidiaries in the United States and Germany to conduct localized operations and has provided services to more than 120 countries and regions worldwide.

With advancements in dental technology and growing demand for customization, digitalization has become a top priority for enhancing the efficiency and quality of oral healthcare. Aidite has proactively embraced this digital transformation by integrating digital solutions into its corporate development and innovation systems.

Currently, Aidite has launched digital transformation initiatives for both its laboratory products and solutions and its clinical products and solutions. Committed to building a dental ecosystem through technology, Aidite strives to become an international leader in advanced dental materials, delivering superior services to dentists and patients alike.

The R&D of high-end dental materials has always been at the core of Aidite.Therefore, in terms of laboratory products and solutions, Aidite is committed to developing competitive digital materials such as zirconia, glass ceramics, and resins. By leveraging CAD/CAM equipment for scanning, design, milling, and rapid sintering, the company has created solutions including 3D Pro Colorful Rapid Aesthetic Restoration and digital complete removable dentures.

Furthermore, the company has developed the Aidite Cloud Platform, which connects dentists, technicians, and other stakeholders in the dental ecosystem to provide design and processing solutions for multiple scenarios.

Building a Digital Dental Ecosystem Centered on Material R&DThis is also a key strategic priority for Aidite. In terms of clinical products and solutions, Aidite has focused on developing a series of digital devices, including the CAMEO chairside restoration system, CAMEO laser therapy device, CAMEO medical loupes, CAMEO clear aligner system, and NAGY caries prevention solution. These offerings are designed to meet the practical needs of dentists, facilitating their delivery of digital restorative, implant, and orthodontic services.

Regarding the advancement of its two digitalization initiatives, Li Hongwen, Founder and CEO of Aidite, stated, “While high-quality equipment, technologies, and solutions help enhance front-end services for dental hospitals and clinics, the core driver of corporate development in the long run remains the research and development and sales of high-end materials.”

As a pioneer in the dental field, Aidite has built a strong reputation within the industry. While pursuing its own growth, the company is also committed to fostering a robust dental ecosystem through its “Two Infinities” strategy.

Currently, Aidite has been recognized as a National High-Tech Enterprise, a Provincial Specialized, Refined, Differential, and Innovative (SRDI) Enterprise, and a Provincial Innovative and Advantageous Pharmaceutical and Medical Device Enterprise. It is a member of the China Green Company Alliance under the China Entrepreneurs Club and holds more than 30 patented technologies.

I. Products and full-process solutions closely align with patient needs.Centered on the digitalization of dentistry, Aidite has conducted collaborative research with professional institutions such as the Chinese Stomatological Association, Peking University School of Stomatology, and West China Hospital of Stomatology, Sichuan University, to gain a profound understanding of clinicians’ needs and develop products that best align with their requirements.

Aidite has also established its own Digital Dental Service Center to provide medical, scientific research, and educational services. By bringing dental digitalization to the forefront of clinical practice, it enables patients to personally experience the aesthetic appeal, speed, and efficiency of digital dentistry.

II. Oral health resources are made infinitely accessible to children and the elderly.As public awareness of oral health protection grows and the demand for dental treatment increases in an aging society, Aidite believes that digital solutions should be developed specifically for elderly dental care as well as adolescent prevention and orthodontic correction.

Regarding the future development of its dental business, Li Hongwen, Founder and CEO of Aidite, stated that Aidite’s products currently hold a significant market share in China and Europe. Looking ahead, Aidite plans to secure a larger international market share and strive to become a top-tier service provider in the dental industry. Meanwhile, the company will increase its investments in R&D and talent acquisition, leveraging technology to build a robust dental ecosystem.

Mr. Li Hongwen, Founder and CEO of Aidite

Regarding this round of financing, Li Hongwen stated“2021 is regarded as the inaugural year of digital dentistry, and the development of the digital economy has also accelerated the process of transformation. Aidite has actively invested in the construction of digital dentistry, building a comprehensive digital system that includes materials, software, and equipment, to bring better products, services, and comprehensive dental solutions to all humanity.”

The lead investor of this funding round stated“We will continue to closely monitor the out-of-pocket medical device market focused on improving quality of life, with dentistry being a representative subsector. Dental applications aimed at aesthetic and functional improvement benefit from a vast addressable population base and rapidly increasing penetration rates driven by consumer demand. Zirconia demonstrates significant competitiveness among denture restorative materials, and its penetration rate in this segment is expected to rise steadily.

Aidite has long maintained a sustained focus on technological and performance enhancements, building strong product capabilities and earning an excellent reputation among its extensive customer base both in China and overseas. Under the leadership of Mr. Li, the company has established a dedicated team that pays meticulous attention to detail, prioritizes customer experience, strives for perfection, and is trustworthy. Actively integrating into the upstream and downstream segments of the digital dentistry industry chain, Aidite seeks to provide customers with more integrated and agile solutions, making its future developments highly anticipated.

Aidite's current shareholder, Legend Capital, stated: “Aidite ranks among the top five globally in the field of dental restorative materials, with its market share in both domestic and international markets continuing to grow. The company offers a diverse product portfolio and boasts technological and quality advantages. Building on its foundation in the dental materials industry, Aidite has actively expanded into chairside digital equipment and has become a leading enterprise in China’s dental digital equipment sector.”

Aidite integrates material capabilities with digital technologies, continuously empowering dental laboratories and clinics through its digital platform, ultimately significantly enhancing consumer comfort. Legend Capital is highly optimistic about Aidite’s future development and firmly believes that Aidite will become a globalized digital dental platform enterprise rooted in China and embracing the world.

Legend Capital is an independent professional investment firm under Legend Holdings. Established in April 2001, it was renamed from Legend Investment to Legend Capital in 2012. Its core business focuses on venture capital for start-ups and growth equity for expanding companies. The total assets under management of its USD and RMB funds exceed RMB 50 billion, with a primary focus on innovation and growth opportunities in China.

Legend Capital’s “invest early, invest long-term, and invest in innovation” strategy in healthcare has been further validated by the market. Currently, Legend Capital’s investment portfolio in the healthcare sector spans innovative drugs and biotechnology, medical devices and diagnostic technologies, as well as professional services and digital health.

Chende Capital is an investment institution focused on the life sciences and medical technology sectors. It manages multiple USD and RMB funds, with total assets under management exceeding RMB 5 billion. Chende Capital is managed and operated by a professional team with extensive experience in the healthcare industry. To date, it has completed investments in over 60 projects and achieved successful exits from multiple portfolio companies.

Leveraging extensive industrial resources across the global and Chinese healthcare sectors, along with years of deep expertise, Chende Capital is positioned to promptly identify emerging international technological trends and seize investment opportunities in China, thereby shaping the future trajectory of the Chinese healthcare market. Chende Capital is committed to building top-tier enterprises in the healthcare sector and delivering optimal returns to its investors.

Zhongjin Qichen Emerging Industry Equity Investment Fund (hereinafter referred to as “Zhongjin Qichen Fund”) is a professional direct investment fund with CICC Capital Management Co., Ltd. (hereinafter referred to as “CICC Capital”) serving as its manager and general partner. CICC Capital is a wholly-owned subsidiary of China International Capital Corporation Limited (hereinafter referred to as “CICC”) and serves as CICC’s sole private equity investment business platform, centrally managing CICC’s domestic and overseas private equity investment businesses. As of the end of 2019, CICC Capital managed assets in excess of RMB 350 billion.

Zhongjin Qichen Fund focuses on investments in the fields of intelligent technology manufacturing and healthcare. Since its establishment, Zhongjin Qichen Fund has made in-depth investments in a number of leading enterprises in niche sectors of the technology and healthcare industries.

Xiamen C&D Emerging Industry Equity Investment Co., Ltd. is a corporate venture capital institution backed by the Fortune Global 500 company Xiamen C&D Group (ranked 234th in the 2020 Fortune Global 500), with assets under management exceeding RMB 10 billion. Guided by its mission to “explore new value and help more high-growth new-economy enterprises achieve better development,” the firm focuses primarily on healthcare, advanced manufacturing, TMT, and consumer sectors. It was consecutively ranked among the “Top 30 Limited Partners in China’s Private Equity Market” for three years from 2018 to 2020.